Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)

NCT00886977 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yoshino Neurology Clinic